LRMR
Larimar Therapeutics
$3.83
−$0.17 (−4.25%)Jul 27, 2026
Key metrics
The numbers that frame LRMR today
- Market cap
- $397.87M
- P/E (TTM)
- -2.4
- EV / FCF
- -1.7
- ROIC
- -449.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.72
- 52wk High
- $6.42
Growth
Revenue and earnings trend for LRMR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LRMR
Is Larimar Therapeutics a good buy?
No. Larimar Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Larimar Therapeutics is selling at a very high price.
What is the market capitalization of LRMR?
Larimar Therapeutics's market capitalization is $397.87M.
What is the P/E ratio for LRMR stock?
Larimar Therapeutics's current P/E ratio is -2.4.
What is the 52-week high for LRMR stock?
The 52-week high for Larimar Therapeutics is $6.42. The current close of $3.83 is 40.3% below that high.
What is the 52-week low for LRMR stock?
The 52-week low for Larimar Therapeutics is $2.72. The current close of $3.83 is 41.1% above that low.
Does LRMR stock pay dividends?
Larimar Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LRMR?
Larimar Therapeutics's Debt / Equity ratio is 0.02.